• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧诱导因子-1α 与短链脂肪酸在炎症性肠病中的相互作用:揭开谜团的关键线索。

Crosstalk between hypoxia-inducible factor-1α and short-chain fatty acids in inflammatory bowel disease: key clues toward unraveling the mystery.

机构信息

Graduate School, Hunan University of Traditional Chinese Medicine, Changsha, China.

Department of Anorectal, the Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha, China.

出版信息

Front Immunol. 2024 Mar 28;15:1385907. doi: 10.3389/fimmu.2024.1385907. eCollection 2024.

DOI:10.3389/fimmu.2024.1385907
PMID:38605960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11007100/
Abstract

The human intestinal tract constitutes a complex ecosystem, made up of countless gut microbiota, metabolites, and immune cells, with hypoxia being a fundamental environmental characteristic of this ecology. Under normal physiological conditions, a delicate balance exists among these complex "residents", with disruptions potentially leading to inflammatory bowel disease (IBD). The core pathology of IBD features a disrupted intestinal epithelial barrier, alongside evident immune and microecological disturbances. Central to these interconnected networks is hypoxia-inducible factor-1α (HIF-1α), which is a key regulator in gut cells for adapting to hypoxic conditions and maintaining gut homeostasis. Short-chain fatty acids (SCFAs), as pivotal gut metabolites, serve as vital mediators between the host and microbiota, and significantly influence intestinal ecosystem. Recent years have seen a surge in research on the roles and therapeutic potential of HIF-1α and SCFAs in IBD independently, yet reviews on HIF-1α-mediated SCFAs regulation of IBD under hypoxic conditions are scarce. This article summarizes evidence of the interplay and regulatory relationship between SCFAs and HIF-1α in IBD, pivotal for elucidating the disease's pathogenesis and offering promising therapeutic strategies.

摘要

人类肠道构成了一个复杂的生态系统,由无数肠道微生物群、代谢物和免疫细胞组成,其中缺氧是该生态系统的基本环境特征。在正常生理条件下,这些复杂的“居民”之间存在着微妙的平衡,破坏这种平衡可能导致炎症性肠病(IBD)。IBD 的核心病理学特征是肠道上皮屏障的破坏,以及明显的免疫和微生物生态紊乱。在这些相互关联的网络中,缺氧诱导因子-1α(HIF-1α)是肠道细胞适应缺氧环境和维持肠道内稳态的关键调节剂。短链脂肪酸(SCFAs)作为重要的肠道代谢物,是宿主和微生物之间的重要介质,对肠道生态系统有重要影响。近年来,人们对 HIF-1α 和 SCFAs 在 IBD 中的作用和治疗潜力进行了独立研究,但关于 HIF-1α 介导的 SCFAs 对缺氧条件下 IBD 的调节作用的综述却很少。本文总结了 IBD 中 SCFAs 和 HIF-1α 之间相互作用和调节关系的证据,这对于阐明疾病的发病机制和提供有前途的治疗策略至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/141a/11007100/2044cc8221d4/fimmu-15-1385907-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/141a/11007100/cd25b0a2343e/fimmu-15-1385907-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/141a/11007100/c03a9dbf56c7/fimmu-15-1385907-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/141a/11007100/2044cc8221d4/fimmu-15-1385907-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/141a/11007100/cd25b0a2343e/fimmu-15-1385907-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/141a/11007100/c03a9dbf56c7/fimmu-15-1385907-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/141a/11007100/2044cc8221d4/fimmu-15-1385907-g003.jpg

相似文献

1
Crosstalk between hypoxia-inducible factor-1α and short-chain fatty acids in inflammatory bowel disease: key clues toward unraveling the mystery.缺氧诱导因子-1α 与短链脂肪酸在炎症性肠病中的相互作用:揭开谜团的关键线索。
Front Immunol. 2024 Mar 28;15:1385907. doi: 10.3389/fimmu.2024.1385907. eCollection 2024.
2
SCFAs induce autophagy in intestinal epithelial cells and relieve colitis by stabilizing HIF-1α.短链脂肪酸通过稳定 HIF-1α 诱导肠道上皮细胞自噬,从而缓解结肠炎。
J Mol Med (Berl). 2020 Aug;98(8):1189-1202. doi: 10.1007/s00109-020-01947-2. Epub 2020 Jul 22.
3
Hypoxia inducible factor-1α-induced interleukin-33 expression in intestinal epithelia contributes to mucosal homeostasis in inflammatory bowel disease.缺氧诱导因子-1α诱导肠道上皮细胞中白细胞介素-33的表达有助于炎症性肠病中的黏膜稳态。
Clin Exp Immunol. 2017 Mar;187(3):428-440. doi: 10.1111/cei.12896. Epub 2016 Dec 6.
4
The role of hypoxia-inducible factor 1-alpha in inflammatory bowel disease.缺氧诱导因子 1-α在炎症性肠病中的作用。
Cell Biol Int. 2022 Jan;46(1):46-51. doi: 10.1002/cbin.11712. Epub 2021 Oct 31.
5
Hypoxic Functional Regulation Pathways in the GI Tract: Focus on the HIF-1α and Microbiota's Crosstalk.胃肠道缺氧功能调节途径:重点关注 HIF-1α与微生物群的相互作用。
Inflamm Bowel Dis. 2024 Aug 1;30(8):1406-1418. doi: 10.1093/ibd/izae046.
6
Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?短链脂肪酸通过肠道屏障、免疫学和微生物群影响炎症性肠病的发展:一种有前途的治疗方法?
J Gastroenterol Hepatol. 2022 Sep;37(9):1710-1718. doi: 10.1111/jgh.15970. Epub 2022 Aug 5.
7
Inflammatory bowel disease is associated with increased gut-to-blood penetration of short-chain fatty acids: A new, non-invasive marker of a functional intestinal lesion.炎症性肠病与短链脂肪酸从肠道向血液渗透增加有关:一种新的、非侵入性的功能性肠道损伤标志物。
Exp Physiol. 2019 Aug;104(8):1226-1236. doi: 10.1113/EP087773. Epub 2019 Jul 10.
8
A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier.短链脂肪酸通过改善肠道屏障来积极影响炎症性肠病、1 型糖尿病和非酒精性脂肪肝:一座桥梁。
Eur J Nutr. 2021 Aug;60(5):2317-2330. doi: 10.1007/s00394-020-02431-w. Epub 2020 Nov 12.
9
Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.细菌代谢产物对肠道屏障功能和宿主免疫的影响:关注细菌代谢及其与肠道炎症的相关性。
Front Immunol. 2021 May 26;12:658354. doi: 10.3389/fimmu.2021.658354. eCollection 2021.
10
The role of microbiota-mitochondria crosstalk in pathogenesis and therapy of intestinal diseases.肠道疾病发病机制和治疗中微生物群-线粒体串扰的作用。
Pharmacol Res. 2022 Dec;186:106530. doi: 10.1016/j.phrs.2022.106530. Epub 2022 Oct 29.

引用本文的文献

1
Unveiling the Cuproptosis in Colitis and Colitis-Related Carcinogenesis: A Multifaceted Player and Immune Moderator.揭示铜死亡在结肠炎及结肠炎相关癌变中的作用:一个多面参与者和免疫调节因子
Research (Wash D C). 2025 May 14;8:0698. doi: 10.34133/research.0698. eCollection 2025.
2
Regulation of innate lymphoid cell by microbial metabolites.微生物代谢产物对固有淋巴细胞的调节作用。
J Mol Med (Berl). 2025 May;103(5):491-509. doi: 10.1007/s00109-025-02530-3. Epub 2025 Mar 25.
3
The causal relationship between immune cell-mediated gut microbiota and ulcerative colitis: a bidirectional two-sample, mediation Mendelian randomization analysis.

本文引用的文献

1
Hyperbaric oxygen augments susceptibility to infection by impairing gut microbiota ability to stimulate the HIF-1α-IL-22 axis in ILC3.高压氧通过损害肠道微生物群落刺激 ILC3 中 HIF-1α-IL-22 轴的能力,增强了对感染的易感性。
Gut Microbes. 2024 Jan-Dec;16(1):2297872. doi: 10.1080/19490976.2023.2297872. Epub 2024 Jan 2.
2
promotes intestinal epithelial IL-18 production through activation of the HIF1α pathway.通过激活缺氧诱导因子1α(HIF1α)信号通路促进肠道上皮细胞白细胞介素-18(IL-18)的产生。
Front Microbiol. 2023 Dec 14;14:1298304. doi: 10.3389/fmicb.2023.1298304. eCollection 2023.
3
Phyllanthus emblica L. polysaccharides ameliorate colitis via microbiota modulation and dual inhibition of the RAGE/NF-κB and MAPKs signaling pathways in rats.
免疫细胞介导的肠道微生物群与溃疡性结肠炎之间的因果关系:双向双样本中介孟德尔随机化分析
Front Nutr. 2024 Oct 25;11:1433545. doi: 10.3389/fnut.2024.1433545. eCollection 2024.
4
Mediating role of chiro-inositol metabolites on the effects of HLA-DR-expressing CD14 + monocytes in inflammatory bowel disease.中介作用的手性肌醇代谢物对 HLA-DR 表达的 CD14 ⁇ 单核细胞在炎症性肠病中的作用。
BMC Gastroenterol. 2024 Jun 17;24(1):200. doi: 10.1186/s12876-024-03271-2.
余甘子多糖通过调节肠道微生物群和双重抑制 RAGE/NF-κB 和 MAPKs 信号通路改善大鼠结肠炎。
Int J Biol Macromol. 2024 Feb;258(Pt 2):129043. doi: 10.1016/j.ijbiomac.2023.129043. Epub 2023 Dec 27.
4
Ento-A alleviates DSS-induced experimental colitis in mice by remolding intestinal microbiota to regulate SCFAs metabolism and the Th17 signaling pathway.肠神经鞘氨醇 1 减轻 DSS 诱导的小鼠实验性结肠炎,其机制为重塑肠道微生物群以调节 SCFAs 代谢和 Th17 信号通路。
Biomed Pharmacother. 2024 Jan;170:115985. doi: 10.1016/j.biopha.2023.115985. Epub 2023 Dec 7.
5
Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease.短链脂肪酸在炎症性肠病中的作用。
Nutrients. 2023 Oct 21;15(20):4466. doi: 10.3390/nu15204466.
6
Role of glycolysis in inflammatory bowel disease and its associated colorectal cancer.糖酵解在炎症性肠病及其相关结直肠癌中的作用。
Front Endocrinol (Lausanne). 2023 Oct 10;14:1242991. doi: 10.3389/fendo.2023.1242991. eCollection 2023.
7
High-fat diet promotes colitis-associated tumorigenesis by altering gut microbial butyrate metabolism.高脂肪饮食通过改变肠道微生物丁酸代谢促进结肠炎相关肿瘤发生。
Int J Biol Sci. 2023 Sep 25;19(15):5004-5019. doi: 10.7150/ijbs.86717. eCollection 2023.
8
The gut microbiota and its biogeography.肠道微生物组及其生物地理学。
Nat Rev Microbiol. 2024 Feb;22(2):105-118. doi: 10.1038/s41579-023-00969-0. Epub 2023 Sep 22.
9
Beyond butyrate: microbial fiber metabolism supporting colonic epithelial homeostasis.除了丁酸盐:支持结肠上皮细胞稳态的微生物纤维代谢。
Trends Microbiol. 2024 Feb;32(2):178-189. doi: 10.1016/j.tim.2023.07.014. Epub 2023 Aug 16.
10
The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials.微生物源短链脂肪酸对疾病中巨噬细胞活性的影响:作用机制与治疗潜力。
Biomed Pharmacother. 2023 Sep;165:115276. doi: 10.1016/j.biopha.2023.115276. Epub 2023 Aug 4.